Parvodicin B1 

Parvodicin B1 is a glycopeptide antibiotic. Parvodicin B1 has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and Enterococcus faecalis. Parvodicin B1 acts by inhibiting the synthesis of bacterial cell wall^[1].

1718.50

C₈₂H₈₆Cl₂N₈O₂₉

110882-82-1

O=C([C@H]1O[C@H]([C@@H]([C@H]([C@@H]1O)O)NC(CCCCCCCC(C)C)=O)OC2=C3OC4=CC=C(C[C@H]5NC([C@@H](C6=CC=C(C(OC7=CC(O)=C(C([C@@H](C(N[C@H]8C(N[C@H]9C(N[C@@H]([C@@H](C%10=CC=C(C(Cl)=C%10)OC2=CC8=C3)O)C(N[C@@H](C%11=CC(O)=CC(O[C@H]%12O[C@@H]([C@H]([C@@H]([C@@H]%12O)O)O)CO)=C%11C%13=C(O)C=CC9=C%13)C(O)=O)=O)=O)=O)=O)NC5=O)=C7)Cl)=C6)O)NC)=O)C=C4)O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. S B Christensen, et al. Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: discovery, taxonomy, activity and structure elucidation. J Antibiot (Tokyo). 1987 Jul;40(7):970-90.  [Content Brief]